Psychometric Evaluation of the Activity Impairment in Migraine-Diary (AIM-D) Using Data from a Phase 3 Clinical Trial (ADVANCE) in Patients with Episodic Migraine (1431)
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
10.1212/wnl.96.15_supplement.1431